Thunder Bridge Capital Partners III Inc *W EXP 02/01/2025
Change company Symbol lookup
Select an option...
TBCPW Thunder Bridge Capital Partners III Inc *W EXP 02/01/2025
FUAPF Global Cannabis Applications Corp
GXG Global X MSCI Colombia ETF
ATMR Altimar Acquisition Corp II
AMD Advanced Micro Devices Inc
BC-A BRUNSWICK 6 500 SENIOR NTS
WST West Pharmaceutical Services Inc
ITT ITT Inc
PLBY Plby Group Inc
SVFA SVF Investment Corp
Go

Company profile

Thunder Bridge Capital Partners III Inc. is a blank check company. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on target businesses in the financial services industry. The Company has not commenced any business operations and has not generated any revenue.

Closing Price
$0.7152
Day's Change
0.0052 (0.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.7152
Day's Low
0.7152
Volume
(Light)
Volume:
224

10-day average volume:
19,966
224

Pfizer expects to have safety and efficacy data for its COVID-19 vaccine in children in late September

7:47 am ET September 15, 2021 (MarketWatch)
Print

Pfizer Inc. (PFE) expects to share data about the safety and efficacy of the COVID-19 vaccine it developed with BioNTech SE (BNTX) for children between the ages of 5 and 11 years old by the end of September, with plans to file for emergency authorization in the U.S. in early October, according to remarks made by company executives on Tuesday. Clinical data for children 6 months old to 5 years old is expected shortly after. "All of that depends on having a positive outcome on the data, right? I'm assuming that in terms of all the dates I'm giving you," Pfizer CFO Frank D'Amelio told investors Tuesday at the Morgan Stanley Global Healthcare Conference, according to a FactSet transcript of the presentation. The BioNTech/Pfizer vaccine is currently authorized for teens between the ages of 12 and 15 years old and is fully approved for those 16 years old and older. Pfizer's stock is up 21.4% this year, while the S&P 500 has gained 18.9%.

-Jaimy Lee

	

(END) Dow Jones Newswires

September 15, 2021 07:47 ET (11:47 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.